IRWD
Ironwood Pharmaceuticals, Inc.
$8.1
Earnings Summary
Revenue | $117.55Mn |
Net Profits | $-1.09Mn |
Net Profit Margins | -0.92% |
Highlights
Ironwood Pharmaceuticals, Inc.’s revenue jumped 9.66% since last year same period to $117.55Mn in the Q4 2023. On a quarterly growth basis, Ironwood Pharmaceuticals, Inc. has generated 3.35% jump in its revenue since last 3-months.
Ironwood Pharmaceuticals, Inc.’s net profit fell -102.22% since last year same period to $-1.09Mn in the Q4 2023. On a quarterly growth basis, Ironwood Pharmaceuticals, Inc. has generated -107.09% fall in its net profits since last 3-months.
Ironwood Pharmaceuticals, Inc.’s net profit margin fell -102.03% since last year same period to -0.92% in the Q4 2023. On a quarterly growth basis, Ironwood Pharmaceuticals, Inc. has generated -106.86% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Ironwood Pharmaceuticals, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | 0.2 |
EPS Estimate Current Year | 0.2 |
Highlights
Ironwood Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.2 - a -4.76% fall from last quarter’s estimates.
Ironwood Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at 0.2.
Key Ratios
Key ratios of the Ironwood Pharmaceuticals, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.01 |
Highlights
Ironwood Pharmaceuticals, Inc.’s earning per share (EPS) fell -103.7% since last year same period to -0.01 in the Q4 2023. This indicates that the Ironwood Pharmaceuticals, Inc. has generated -103.7% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-09 | 0.16 | 0.09 | -43.75% |
2023-05-04 | 0.24 | 0.25 | 4.17% |
2023-08-09 | 0.25 | 0.31 | 24% |
2024-02-16 | 0.21 | -0.01 | -104.76% |
₹0 US Stocks a/c Opening Fee